Medrio, a Leading provider of EDC, Announces M-1 Product for Phase I Clinical Trials at DIA and BIO Industry Conferences

Medrio, a Leading provider of EDC, Announces M-1 Product for Phase I Clinical Trials at DIA and BIO Industry Conferences

Medrio's M-1 is Ideal for Phase 1 Trials

San Francisco, CA (PRWEB) July 02, 2014

Medrio, a provider of eClinical Software As A Service (SaaS) for clinical research, announced its M-1 product while an exhibitor at both DIA 2014 and BIO 2014. The two conferences brought together industry leaders across pharmaceutical and biotech fields for back to back weeks in San Diego.

BIO and DIA's positive impact on Medrio was evident as hundreds of companies, including sponsors and CROs, visited Medrio's booths to learn more about its eClinical software, and M-1 specifically.

"It was exciting to have the opportunity to showcase our new product at both DIA and BIO this year," said Scott Weidley, Vice President of Sales and Marketing. "We continue to focus on the features that our customers care about most. In the case of M-1, we wanted to address the specific needs of our customers who are conducting Phase I research."

About Medrio, Inc.
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information visit http://www.medrio.com.

About DIA 2014
The DIA 2014 50th Annual Meeting is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients. For more information visit: http://www.diahome.org.

About BIO 2014
The largest, most influential biotech meeting in the world is coming to the San Diego Convention Center, June 23 – 26, 2014, offering four days of career-boosting opportunities that you won't find anywhere else—from sessions and specialty forums covering 17 hot topics to networking events, 1,700+ exhibitors and BIO One-on-One PartneringTM meetings with thousands of companies. Join the global biotech community in San Diego and discover where BIO 2014 can take you. For more information visit: http://www.convention.bio.org.